CTR20262064 clinical trial report covering CKBA, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20261992 clinical trial report covering VG2062, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600125356 clinical trial report covering Etoposide, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07607210 clinical trial report covering Retlirafusp alfa, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07607418 clinical trial report covering Ivosidenib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20261971 clinical trial report covering BAY-1158061, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20262096 clinical trial report covering Golden Fangfeng Teabag, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07605949 clinical trial report covering Venetoclax, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07607561 clinical trial report covering Axitinib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07605416 clinical trial report covering Lenalidomide, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600125446 clinical trial report covering KAL-002, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20261989 clinical trial report covering Ropivacaine Hydrochloride, Phase 2, endpoints, sponsor, geography, readout timing and development white space.